Pre-Clinical Evaluation of a Novel Domain Antibody Targeting CD154 in a Non-Human Primate Transplant Model.
W. Wakwe(Emory University), Andrew Adams(University of Minnesota), Elizabeth Strobert(Emory University), Carsten Schade Larsen(Emory Healthcare), Alton B. Farris, Cynthia Breeden(Emory University), F. Leopardi(Emory Healthcare), Karen Price(Purchase College), Manshu Song(Edith Cowan University), S. Nadler(Bristol-Myers Squibb (United States)), J. Jenkins(Emory National Primate Research Center)
Cited by 0
Related Papers
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
Renal interstitial fibrosis
|Current Opinion in Nephrology & Hypertension|2012|294
Morphometric and Visual Evaluation of Fibrosis in Renal Biopsies
|Journal of the American Society of Nephrology|2010|234